Follow
Shahin Merat
Title
Cited by
Cited by
Year
Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to …
C Fitzmaurice, C Allen, RM Barber, L Barregard, ZA Bhutta, H Brenner, ...
JAMA oncology 3 (4), 524-548, 2017
69472017
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4· 4 million participants
B Zhou, Y Lu, K Hajifathalian, J Bentham, M Di Cesare, G Danaei, H Bixby, ...
The lancet 387 (10027), 1513-1530, 2016
40672016
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
20562017
The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease …
S Alatab, SG Sepanlou, K Ikuta, H Vahedi, C Bisignano, S Safiri, ...
The Lancet gastroenterology & hepatology 5 (1), 17-30, 2020
16232020
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
14642018
The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
SG Sepanlou, S Safiri, C Bisignano, KS Ikuta, S Merat, M Saberifiroozi, ...
The Lancet gastroenterology & hepatology 5 (3), 245-266, 2020
11492020
The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the …
A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ...
The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019
765*2019
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study
F Islami, A Pourshams, D Nasrollahzadeh, F Kamangar, S Fahimi, ...
Bmj 338, 2009
3732009
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study
S Blach, NA Terrault, F Tacke, I Gamkrelidze, A Craxi, J Tanaka, I Waked, ...
The Lancet Gastroenterology & Hepatology 7 (5), 396-415, 2022
2912022
Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial
G Roshandel, M Khoshnia, H Poustchi, K Hemming, F Kamangar, ...
The Lancet 394 (10199), 672-683, 2019
2502019
Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran
R Malekzadeh, M Sotoudeh, MH Derakhshan, J Mikaeli, A Yazdanbod, ...
Journal of clinical pathology 57 (1), 37-42, 2004
2492004
Socio-economic status and oesophageal cancer: results from a population-based case–control study in a high-risk area
F Islami, F Kamangar, D Nasrollahzadeh, K Aghcheli, M Sotoudeh, ...
International journal of epidemiology 38 (4), 978-988, 2009
2432009
Hepatitis B in Iran
SH Merat, R Malekzadeh, H Rezvan, M Khatibian
ARCHIVES OF IRANIAN MEDICINE 3 (4), 0-0, 2000
2352000
The effect of fluoxetine in patients with pain and constipation‐predominant irritable bowel syndrome: a double‐blind randomized‐controlled study
H Vahedi, S Merat, A Rashidioon, A Ghoddoosi, R Malekzadeh
Alimentary pharmacology & therapeutics 22 (5), 381-385, 2005
2282005
Epidemiologic features of upper gastrointestinal tract cancers in Northeastern Iran
F Islami, F Kamangar, K Aghcheli, S Fahimi, S Semnani, N Taghavi, ...
British journal of cancer 90 (7), 1402-1406, 2004
2192004
The effect of enteric-coated, delayed-release peppermint oil on irritable bowel syndrome
S Merat, S Khalili, P Mostajabi, A Ghorbani, R Ansari, R Malekzadeh
Digestive diseases and sciences 55, 1385-1390, 2010
2142010
Statins for non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis
L Eslami, S Merat, R Malekzadeh, S Nasseri‐Moghaddam, H Aramin
Cochrane Database of Systematic Reviews, 2013
2072013
Synbiotic supplementation in lean patients with non-alcoholic fatty liver disease: a pilot, randomised, double-blind, placebo-controlled, clinical trial
F Mofidi, H Poustchi, Z Yari, B Nourinayyer, S Merat, M Sharafkhah, ...
British Journal of Nutrition 117 (5), 662-668, 2017
2052017
Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma
CC Abnet, F Kamangar, F Islami, D Nasrollahzadeh, P Brennan, ...
Cancer Epidemiology Biomarkers & Prevention 17 (11), 3062-3068, 2008
2052008
Clinical trial: the effect of amitriptyline in patients with diarrhoea‐predominant irritable bowel syndrome
H Vahedi, S Merat, S Momtahen, AS Kazzazi, N Ghaffari, G Olfati, ...
Alimentary pharmacology & therapeutics 27 (8), 678-684, 2008
2052008
The system can't perform the operation now. Try again later.
Articles 1–20